Omepron 40Mg Vl
Description : Each IV injection combination pack contains a vial containing omeprazole sodium (freeze-dried powder) 42.6 mg equivalent to omeprazole 40 mg, and an ampoule of solvent containing polyethylene glycol 400 4,000 mg, citric acid monohydrate 6 mg and water for injection added to make 10 mL.
Indications / Uses : Benign gastric ulcer, duodenal ulcer, gastroesophageal reflux disease.
Acid aspiration prophylaxis. The injection may be used as an alternative for patients who cannot tolerate oral therapy.
Administration : Should be taken with food: Take immediately before a meal.
Contraindications : Hypersensitivity to omeprazole or to any components of Omepron.
Special Precautions : Symptomatic response to omeprazole therapy does not rule out the presence of a gastric malignancy. Atrophic gastritis has been noted occasionally in gastric corpus biopsies from patients on long-term omeprazole therapy.
Use in pregnancy & lactation: Omeprazole should be used in pregnancy only if the potential benefit justifies the potential risk to the fetus.
It is not known whether omeprazole is excreted in human milk. Because many drugs are excreted in human milk, the potential for serious adverse reactions in nursing infants, and omeprazole’s potential for tumorigenicity shown in rat carcinogenicity studies, a decision should be made whether to discontinue the drug, taking into account the importance of the drug to the mother.
Use in children: Safety and effectiveness in pediatric patients have not been established.